Clinical Efficacy and Pharmacokinetics of Antivenom Viperfav<sup>®</sup> in <i>Vipera ammodytes ammodytes</i> Envenomation
<b>Background:</b> In Europe, <i>Vipera ammodytes ammodytes</i> (<i>Vaa</i>, nose-horned viper) is considered the most venomous of the European vipers. The antivenom Viperfav<sup>®</sup>, composed of polyvalent equine F(ab′)<sub>2</sub> fragments, is effective against <i>Vipera aspis</i>, <i>Vipera...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
MDPI AG
2025-11-01
|
| Rangatū: | Pharmaceutics |
| Ngā marau: | |
| Urunga tuihono: | https://www.mdpi.com/1999-4923/17/11/1431 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|